Publication | Closed Access

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

Surgical OncologyOncologyGastrointestinal OncologyBiliary CancerPathologyCancer TreatmentPhase 2Multicentre Basket TrialMedicineRadiation OncologyCancer ResearchMolecular Oncology